137 related articles for article (PubMed ID: 9595506)
1. Mechanism of endothelin-induced malignant ventricular arrhythmias in dogs.
Merkely B; Gellér L; Tóth M; Kiss O; Kékesi V; Solti F; Vecsey T; Horkay F; Tenczer J; Juhász-Nagy A
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S437-9. PubMed ID: 9595506
[TBL] [Abstract][Full Text] [Related]
2. Increased monophasic action potential dispersion in endothelin-1-induced ventricular arrhythmias.
Gellér L; Merkely B; Lang V; Szabó T; Fazekas L; Kékesi V; Kiss O; Horkay F; Schaldach M; Tóth M; Juhász-Nagy A
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S434-6. PubMed ID: 9595505
[TBL] [Abstract][Full Text] [Related]
3. Bradycardia increases the arrhythmogenic effect of endothelin.
Tóth M; Solti F; Merkely B; Kékesi V; Szokodi I; Horkay F; Juhász-Nagy A
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S431-3. PubMed ID: 9595504
[TBL] [Abstract][Full Text] [Related]
4. Intracoronary endothelin-1 infusion combined with systemic isoproterenol treatment: antagonistic arrhythmogenic effects.
Kiss O; Zima E; Soós P; Kékesi V; Juhász-Nagy A; Merkely B
Life Sci; 2004 Jun; 75(5):537-48. PubMed ID: 15158364
[TBL] [Abstract][Full Text] [Related]
5. Investigating the dual nature of endothelin-1: ischemia or direct arrhythmogenic effect?
Szabó T; Gellér L; Merkely B; Selmeci L; Juhász-Nagy A; Solti F
Life Sci; 2000 May; 66(26):2527-41. PubMed ID: 10883731
[TBL] [Abstract][Full Text] [Related]
6. Intrapericardial infusion of endothelin-1 induces ventricular arrhythmias in dogs.
Szokodi I; Horkay F; Merkely B; Solti F; Gellér L; Kiss P; Selmeci L; Kékesi V; Vuolteenaho O; Ruskoaho H; Juhász-Nagy A; Tóth M
Cardiovasc Res; 1998 May; 38(2):356-64. PubMed ID: 9709396
[TBL] [Abstract][Full Text] [Related]
7. Bosentan the mixed endothelin-A- and -B-receptor antagonist suppresses intrapericardial endothelin-1-induced ventricular arrhythmias.
Horkay F; Gellér L; Kiss O; Szabó T; Vagó H; Kékesi V; Juhász-Nagy A; Merkely B
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S320-2. PubMed ID: 11078409
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-A-receptor antagonist LU 135.252 inhibits the formation of ventricular arrhythmias caused by intrapericardial infusion of endothelin-1.
Kiss O; Gellér L; Merkely B; Szabó T; Raschack M; Seres L; Zima E; Juhász-Nagy A; Horkay F
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S317-9. PubMed ID: 11078408
[TBL] [Abstract][Full Text] [Related]
9. Verapamil reduces the arrhythmogenic effect of endothelin.
Solti F; Tóth M; Merkely B; Kékesi V; Gellér L; Szokodi I; Horkay F; Juhász-Nagy A
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S386-7. PubMed ID: 9595491
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological effects of intrapericardial infusion of endothelin-1.
Gellér L; Merkely B; Szokodi I; Szabó T; Vecsey T; Juhász-Nagy A; Tóth M; Horkay F
Pacing Clin Electrophysiol; 1998 Jan; 21(1 Pt 2):151-6. PubMed ID: 9474663
[TBL] [Abstract][Full Text] [Related]
11. Fundamental electrophysiological differences between low-dose intracoronary endothelin-1 infusion and myocardial ischemia revealed by multiple monophasic action potential recording.
Gellér L; Szabó T; Kiss O; Solti F; Juhász-Nagy A; Merkely B
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S167-71. PubMed ID: 11078368
[TBL] [Abstract][Full Text] [Related]
12. Early and delayed afterdepolarizations associated with cesium chloride-induced arrhythmias in the dog.
Patterson E; Szabo B; Scherlag BJ; Lazzara R
J Cardiovasc Pharmacol; 1990 Feb; 15(2):323-31. PubMed ID: 1689430
[TBL] [Abstract][Full Text] [Related]
13. The selective endothelin-A-receptor antagonist LU 135.252 inhibits the direct arrhythmogenic action of endothelin-1.
Merkely B; Szabó T; Gellér L; Kiss O; Horkay F; Raschack M; Juhász-Nagy A
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S314-6. PubMed ID: 11078407
[TBL] [Abstract][Full Text] [Related]
14. Ventricular tachycardias induced by intracoronary administration of endothelin-1 in dogs.
Tóth M; Solti F; Merkely B; Kékesi V; Horkay F; Szokodi I; Juhász-Nagy A
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S153-5. PubMed ID: 8587349
[TBL] [Abstract][Full Text] [Related]
15. Proarrhythmic activity of intracoronary endothelin in dogs: relation to the site of administration and to changes in regional flow.
Salvati P; Chierchia S; Dho L; Ferrario RG; Parenti P; Vicedomini G; Patrono C
J Cardiovasc Pharmacol; 1991 Jun; 17(6):1007-14. PubMed ID: 1714004
[TBL] [Abstract][Full Text] [Related]
16. Potential pathophysiologic role of endothelin-1 in canine pericardial fluid.
Horkay F; Szokodi I; Merkely B; Solti F; Gellér L; Kiss P; Selmeci L; Horváth I; Kékesi V; Juhász-Nagy A; Tóth M
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S401-2. PubMed ID: 9595496
[TBL] [Abstract][Full Text] [Related]
17. Expressed monophasic action potential alternans before the onset of ventricular arrhythmias induced by intracoronary bolus administration of endothelin-1 in dogs.
Merkely B; Vágó H; Kiss O; Zima E; Szücs G; Gellér L; Juhász-Nagy A
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():219S-222S. PubMed ID: 12193090
[TBL] [Abstract][Full Text] [Related]
18. QTU prolongation and polymorphic ventricular tachyarrhythmias due to bradycardia-dependent early afterdepolarizations. Afterdepolarizations and ventricular arrhythmias.
el-Sherif N; Zeiler RH; Craelius W; Gough WB; Henkin R
Circ Res; 1988 Aug; 63(2):286-305. PubMed ID: 3396153
[TBL] [Abstract][Full Text] [Related]
19. Ventricular arrhythmias following one-stage and two-stage coronary reperfusion: evidence for both reentry and enhanced automaticity.
Kabell G; Scherlag BJ; Brachmann J; Harrison L; Lazzara R
J Electrocardiol; 1985 Jan; 18(1):87-96. PubMed ID: 2579181
[TBL] [Abstract][Full Text] [Related]
20. Effects of experimental diabetes on endothelin-induced ventricular arrhythmias in dogs.
Pósa I; Horkay F; Seres L; Skoumal R; Kováts T; Balogh E; de Châtel R; Tóth M; Kocsis E
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S380-2. PubMed ID: 15838325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
